Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Alport Syndrome: early-phase trial registry
3 of 6 indexed Alport Syndrome trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Alport Syndrome: 6 US clinical trials tracked, 3 recruiting.
Alport Syndrome is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Alport Syndrome Foundation, running 1 of these trials.
Enrollment posture brief
Registry condition alport-syndrome
OPEN 3 | RECR 50% | LATE 0 | EARLY 3 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achalasia (50% recruiting · 8 trials)
Alport Syndrome lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Alport Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Alport Syndrome is recruiting above its size-band peers.
3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Alport Syndrome research.
Alport Syndrome Foundation accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Alport Syndrome enrolment sits around 103 participants.
Median target enrolment is 103 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.
-
Alport Syndrome splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
ASF Alport Patient Registry
Alport Syndrome Foundation
NCT06526741
NEPTUNE Match Study
University of Michigan
NCT04571658
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Travere Therapeutics
NCT05003986
Atrasentan in Patients With Proteinuric Glomerular Diseases
Novartis Pharmaceuticals
NCT04573920
A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome
University of Minnesota
NCT00622544
A Study of RG-012 in Subjects With Alport Syndrome
Genzyme, a Sanofi Company
NCT03373786
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Alport Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Alport Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Alport Syndrome page
6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Alport Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Alport Syndrome Foundation sponsors the most Alport Syndrome trials on record, review their full trial history before evaluating a specific study. See Alport Syndrome Foundation's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Alport Syndrome condition card totals 6 registered trials; most-linked intervention RG012; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.